Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation.

Description: Michael Pearson and his company, Valeant Pharmaceuticals International Inc., were supposed to calm Wall Street doubters on Tuesday. Instead: chaos.

Source: Bloomberg.com – video report

Date: Mar 15, 2016

Link: http://www.bloomberg.com/news/articles/2016-03-15/after-a-600-million-typo-valeant-s-ceo-is-back-on-the-hot-seat

Questions for Discussions:

  • Summarize the reasons for Valeant’s share value collapse, according to the report.
  • Do you think it has collapsed completely and offers no future value to investors?

Leave a Reply

Your email address will not be published.